Evidence map›Paper›PMID 28688920›Full record

ArticleToxicology and applied pharmacology2017

Single-cell RNA sequencing reveals an altered gene expression pattern as a result of CRISPR/cas9-mediated deletion of Gene 33/Mig6 and chronic exposure to hexavalent chromium in human lung epithelial cells.

Soyoung Park, Xiaowen Zhang, Cen Li, Changhong Yin, Jiangwei Li, John T Fallon, Weihua Huang, Dazhong Xu

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Soyoung ParkDepartment of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.
Xiaowen ZhangDepartment of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.
Cen LiDepartment of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.
Changhong YinDepartment of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.
Jiangwei LiDepartment of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.
John T FallonDepartment of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.
Weihua HuangDepartment of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.
Dazhong XuDepartment of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States. Electronic address: Dazhong_xu@nymc.edu.
New York Medical College · US

Funding

Plk3 in nickel-induced lung carcinogenesisR21ES023862 · NIEHS · NEW YORK MEDICAL COLLEGE · PI XU, DAZHONG · 2014 to 2015
$432k
NIEHS NIH HHS R21 ES023862
6 · The paper itself

Abstract

Gene 33 (Mig6, ERRFI1) is an adaptor protein with multiple cellular functions. We recently reported that depletion of this protein promotes lung epithelial cell transformation induced by hexavalent chromium [Cr(VI)]. However, the early molecular events that mediate this process are not clear. In the present study, we used single-cell RNA sequencing to compare gene expression profiles between BEAS-2B lung epithelial cells chronically exposed to a sublethal dose of Cr(VI) with or without CRISPR/cas9-mediated deletion of Gene 33. Our data reveal 83 differentially expressed genes. The most notable changes are genes associated with cell adhesion, oxidative stresses, protein ubiquitination, epithelial-mesenchymal transition/metastasis, and WNT signaling. Up-regulation of some neuro-specific genes is also evident, particularly ubiquitin carboxyl-terminal hydrolase L1 (UCHL1), a deubiquitinase and potential biomarker for lung cancer. Gene 33 deletion and/or Cr(VI) exposure did not cause discernable changes in cell morphology. However, Gene 33 deletion led to a modest but significant reduction of cells in the G2/M phase of the cell cycle regardless of Cr(VI) exposure. Gene 33 deletion also significantly reduced cell proliferation. Interestingly, Cr(VI) exposure eliminated the difference in cell proliferation between the two genotypes. Gene 33 deletion also significantly elevated cell migration. Our data indicate that combined Gene 33 deletion and chronic Cr(VI) exposure produces a gene expression pattern and a phenotype resemble those of the transformed lung epithelial cells. Given the known association of UCHL1 with lung cancer, we propose that UCHL1 is an important player in the early stage of lung epithelial cell transformation and tumorigenesis.

Indexed as

Adaptor Proteins, Signal TransducingCarcinogensCell CycleCell LineCell MovementCell ProliferationChromiumCRISPR-Cas SystemsEnvironmental PollutantsEpithelial CellsGene ExpressionGene Expression Regulation, NeoplasticHumansRNASequence Analysis, RNATumor Suppressor ProteinsAdaptor Proteins, Signal TransducingCarcinogensChromiumchromium hexavalent ionEnvironmental PollutantsERRFI1 protein, humanRNATumor Suppressor ProteinsCarcinogenesisChromiumGene 33/Mig6LungRNA-seqSingle cell

Identifiers

PMID28688920
PMCPMC5562372
OpenAlexW2725058010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.